Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel Vivus Inc.'s weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. The shares doubled in late trading. Diet drug Qnexa should be approved, panel says The diet drug Qnexa has cleared a major hurdle toward eventual Food and Drug Administration approval. An independent panel of medical experts who advise the agency voted Wednesday that Qnexa's significant weight-loss benefit outweighed its potential risks. FDA advisors endorse weight-loss drug Qnexa In a reversal, an FDA advisory committee backs the weight-loss drug Qnexa despite health risks after its maker, Vivus, promises strict oversight. A panel of medical experts voted overwhelmingly Wednesday to endorse the controversial weight-loss drug Qnexa, clearing the way for the Food and Drug Administration to approve a new prescription obesity medication for the first time since 1999. Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Advisory Panel Vivus Inc. (VVUS) 's weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. If Qnexa gets the green light, who would get the drug? An advisory committee's hearty 20-to-2 vote to recommend approval of the obesity drug Qnexa on Wednesday means it's highly likely the FDA will allow the medication to be marketed when the agency issues its final report later this year. If approved, Qnexa will be the first new prescription weight-loss medication in 13 years. Qnexa Weight-Loss Drug Wins Advisory Panel's Support A committee recommended that the Food and Drug Administration approve what could become the first new prescription drug to treat obesity in 13 years. FDA Panel Recommends Approval of Diet Drug Qnexa A U.S. Food and Drug Administration Advisory Committee today recommended approval of the weight loss drug Qnexa, a treatment many hope will help millions of Americans who struggle with obesity. In voting 20 to 2 for approval, the committee said today that Qnexa's weight loss... FDA Weighs Fate of Qnexa for Weight Loss, Again Title: FDA Weighs Fate of Qnexa for Weight Loss, Again Category: Health News Created: 2/21/2012 10:05:00 AM Last Editorial Review: 2/21/2012 At Qnexa hearing, public commenters are split on the drug's value Qnexa, an investigational drug to promote weight loss, has divided public health advocates, based on comments made Wednesday at a Food and Drug Administration advisory committee hearing. Diet Drug Qnexa Gets Thumbs-Up From FDA Panel In a reversal, a panel of experts is advising the Food and Drug Administration to approve Qnexa, a weight-loss pill, that was rejected in 2010. The potential benefits for overweight people exceed the risks, such as birth defects and increased heart rates, the panel determined.
Key Words: qnexa
References:
http://feedproxy.google.com/~r/orlandosentinel/news/local/southwest/~3/Qg4sLpAyIGc/sns-bc-us--dietpill-fdameeting,0,6216893.story
http://feeds.latimes.com/~r/latimes/news/science/~3/E8KkIvdBTOs/la-he-qnexa-fda-20120223,0,7015694.story
http://ChicagoTribune.feedsportal.com/c/34253/f/622900/s/1cdc94c2/l/0L0Schicagotribune0N0Chealth0Cla0Eheb0Eqnexa0Epatients0E20A120A2220H0A0H4610A40A0Bstory0Dtrack0Frss/story01.htm
http://feeds.wsjonline.com/~r/wsj/xml/rss/3_7198/~3/5cYWHOyi5Bo/SB10001424052970203960804577239642544675320.html
http://video.msnbc.msn.com/nightly-news/46489035/
http://rssfeeds.usatoday.com/~r/usatoday-NewsTopStories/~3/wxHzKHaW-FE/1
http://feeds.wsjonline.com/~r/wsj/health/feed/~3/wsmunDa7f44/
http://www.forbes.com/sites/larryhusten/2012/02/22/fda-advisory-panel-gives-green-light-to-qnexa-diet-pill/
http://pixelhat.net/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.